PT Pyridam Farma Tbk (PYFA.JK)
IDR 212.0
(0.95%)
IDR 212.0
(0.95%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 225.48 Billion IDR | 7.27% |
| 2022 | 210.19 Billion IDR | 44.03% |
| 2021 | 145.94 Billion IDR | 185.96% |
| 2020 | 51.03 Billion IDR | 15.28% |
| 2019 | 44.26 Billion IDR | 6.44% |
| 2018 | 41.59 Billion IDR | 12.74% |
| 2017 | 36.89 Billion IDR | -8.46% |
| 2016 | 40.3 Billion IDR | 11.44% |
| 2015 | 36.16 Billion IDR | 12.11% |
| 2014 | 32.25 Billion IDR | -10.06% |
| 2013 | 35.86 Billion IDR | 43.2% |
| 2012 | 25.04 Billion IDR | -15.16% |
| 2011 | 29.52 Billion IDR | 38.38% |
| 2010 | 21.33 Billion IDR | -11.37% |
| 2009 | 24.07 Billion IDR | 35.67% |
| 2008 | 17.74 Billion IDR | 39.46% |
| 2007 | 12.72 Billion IDR | 39.26% |
| 2006 | 9.13 Billion IDR | 16.94% |
| 2005 | 7.81 Billion IDR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 248.08 Billion IDR | 10.02% |
| 2024 Q3 | 512.22 Billion IDR | 6.08% |
| 2024 Q2 | 482.87 Billion IDR | 94.64% |
| 2023 Q4 | 225.48 Billion IDR | 0.65% |
| 2023 Q1 | 229.92 Billion IDR | 9.39% |
| 2023 Q2 | 235.49 Billion IDR | 2.42% |
| 2023 FY | 225.48 Billion IDR | 7.27% |
| 2023 Q3 | 224.03 Billion IDR | -4.87% |
| 2022 Q2 | 161.65 Billion IDR | 5.32% |
| 2022 FY | 210.19 Billion IDR | 44.03% |
| 2022 Q4 | 210.19 Billion IDR | 8.31% |
| 2022 Q1 | 153.48 Billion IDR | 5.17% |
| 2022 Q3 | 194.06 Billion IDR | 20.05% |
| 2021 Q3 | 84.61 Billion IDR | 18.57% |
| 2021 Q2 | 71.36 Billion IDR | 6.26% |
| 2021 Q1 | 67.15 Billion IDR | 31.59% |
| 2021 FY | 145.94 Billion IDR | 185.96% |
| 2021 Q4 | 145.94 Billion IDR | 72.48% |
| 2020 Q1 | 41.98 Billion IDR | -5.15% |
| 2020 FY | 51.03 Billion IDR | 15.28% |
| 2020 Q4 | 51.03 Billion IDR | -9.05% |
| 2020 Q3 | 56.11 Billion IDR | -3.69% |
| 2020 Q2 | 58.26 Billion IDR | 38.75% |
| 2019 Q3 | 40.74 Billion IDR | 9.28% |
| 2019 Q4 | 44.26 Billion IDR | 8.64% |
| 2019 Q2 | 37.29 Billion IDR | -8.86% |
| 2019 FY | 44.26 Billion IDR | 6.44% |
| 2019 Q1 | 40.91 Billion IDR | -1.62% |
| 2018 Q1 | 36.16 Billion IDR | -1.96% |
| 2018 FY | 41.59 Billion IDR | 12.74% |
| 2018 Q4 | 41.59 Billion IDR | 6.69% |
| 2018 Q3 | 38.98 Billion IDR | -0.41% |
| 2018 Q2 | 39.13 Billion IDR | 8.21% |
| 2017 FY | 36.89 Billion IDR | -8.46% |
| 2017 Q2 | 35.1 Billion IDR | -12.83% |
| 2017 Q1 | 40.26 Billion IDR | -0.08% |
| 2017 Q3 | 34.1 Billion IDR | -2.86% |
| 2017 Q4 | 36.89 Billion IDR | 8.18% |
| 2016 Q3 | 39.6 Billion IDR | 12.69% |
| 2016 Q1 | 34.07 Billion IDR | -5.77% |
| 2016 FY | 40.3 Billion IDR | 11.44% |
| 2016 Q4 | 40.3 Billion IDR | 1.77% |
| 2016 Q2 | 35.14 Billion IDR | 3.12% |
| 2015 Q3 | 38.05 Billion IDR | -7.3% |
| 2015 FY | 36.16 Billion IDR | 12.11% |
| 2015 Q1 | 36.06 Billion IDR | 11.79% |
| 2015 Q2 | 41.05 Billion IDR | 13.85% |
| 2015 Q4 | 36.16 Billion IDR | -4.97% |
| 2014 Q4 | 32.25 Billion IDR | 1.52% |
| 2014 FY | 32.25 Billion IDR | -10.06% |
| 2014 Q3 | 31.77 Billion IDR | -16.41% |
| 2014 Q2 | 38 Billion IDR | 1.89% |
| 2014 Q1 | 37.3 Billion IDR | 4.0% |
| 2013 FY | 35.86 Billion IDR | 43.2% |
| 2013 Q2 | 25.83 Billion IDR | 29.95% |
| 2013 Q3 | 29.59 Billion IDR | 14.57% |
| 2013 Q4 | 35.86 Billion IDR | 21.2% |
| 2013 Q1 | 19.87 Billion IDR | -20.63% |
| 2012 Q1 | 29.84 Billion IDR | 1.1% |
| 2012 FY | 25.04 Billion IDR | -15.16% |
| 2012 Q2 | 30.28 Billion IDR | 1.47% |
| 2012 Q3 | 34.66 Billion IDR | 14.47% |
| 2012 Q4 | 25.04 Billion IDR | -27.75% |
| 2011 Q4 | 29.52 Billion IDR | 0.0% |
| 2011 FY | 29.52 Billion IDR | 38.38% |
| 2010 FY | 21.33 Billion IDR | -11.37% |
| 2009 FY | 24.07 Billion IDR | 35.67% |
| 2008 FY | 17.74 Billion IDR | 39.46% |
| 2007 FY | 12.72 Billion IDR | 39.26% |
| 2006 FY | 9.13 Billion IDR | 16.94% |
| 2005 FY | 7.81 Billion IDR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 452.64 Billion IDR | 50.185% |
| PT Merck Tbk | 377.19 Billion IDR | 40.221% |
| PT Phapros, Tbk | 301.13 Billion IDR | 25.121% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 408.45 Billion IDR | 44.796% |
| PT Tempo Scan Pacific Tbk | 1865.03 Billion IDR | 87.91% |